Publications by authors named "Wang-Ting Hung"
Article Synopsis
- This study compared the effectiveness of dipyridamole-based triple antiplatelet therapy versus dual antiplatelet therapy (DAPT) for preventing strokes and improving long-term outcomes in patients with acute myocardial infarction (AMI) and a history of stroke.
- Analyzed data from 4,468 DAPT patients and 1,117 Dipyridamole-DAPT patients showed that overall long-term survival was similar, but DAPT performed better after the first year, especially in younger patients and those undergoing percutaneous coronary intervention (PCI).
- Dipyridamole-DAPT showed no benefit in reducing recurrent strokes or myocardial infarctions and was linked to an increased risk of intracerebral hemorrhage, indicating that
Article Synopsis
- This research aimed to explore the impact of sepsis on survival rates in patients experiencing their first acute myocardial infarction (AMI), revealing a correlation between systemic infection and increased mortality.
- A nationwide study in Taiwan analyzed data from over 180,000 patients with AMI, finding that 7% were diagnosed with sepsis, which was linked to a significantly lower 12-year survival rate and longer hospital stays.
- The study concluded that sepsis serves as an independent risk factor for increased mortality following AMI, while interventions like percutaneous coronary intervention (PCI) positively influenced survival outcomes for both sepsis and non-sepsis patients.
Article Synopsis
- - The study investigated how hepatitis C virus (HCV) infection affects long-term mortality in patients who suffered an acute myocardial infarction (AMI), using data from Taiwan's National Health Insurance Research Database.
- - Among over 186,000 first AMI cases analyzed, patients with HCV and cirrhosis showed significantly higher 12-year mortality rates compared to those without cirrhosis and matched controls, indicating a strong link between HCV and worse outcomes.
- - Results highlighted that HCV infection increased mortality rates particularly among males and hypertensive patients, with cirrhosis exacerbating this risk.
Background: Previous studies regarding the cardioprotective effects of dipeptidyl peptidase 4 (DPP-4) inhibitors have not provided sufficient evidence of a relationship between DPP-4 inhibition and actual cardiovascular outcomes. This study aimed to evaluate the impact of DPP-4 inhibitors on the survival of diabetic patients after first acute myocardial infarction (AMI).
Methods: This was a nationwide, propensity score-matched, case-control study of 186,112 first AMI patients, 72,924 of whom had diabetes.